Bruce Bentley

TOKYO , Jan 20, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa Ph.D., "Astellas") announced today that the US Food and Drug Administration (FDA) has lifted the clinical hold on Jan 19 th for the FORTIS Ph1/2 clinical trial evaluating the safety, tolerability and efficacy of investigational AT845 in adults with late-onset Pompe disease (LOPD). "With that same spirit and focus on patient safety, we look forward to resuming the FORTIS clinical trial and the continued development of AT845 as an important potential new treatment for adults living with LOPD," said ha tran , Executive Medical Director for Astellas. "As always, we are grateful to the patients participating in the FORTIS clinical trial and we remain committed to developing novel therapies for those with a high unmet medical need." Following the clinical hold lift, Astellas is working on completing the clinical and regulatory activities necessary to resu

Asia Culture Center (ACC) is seeking participants for ACC Residency 2023. ACC has been organizing international residency programs not just as a form of artistic support policy, but a superlative creation/production program to produce novel and diverse content with creative talents from all over the world. As a forum for experimentation and exchange it envisions alternative futures based on a spirit of artistic engagement with reality. This year, the residency will be held in collaboration with ACC Sound Art Lab under the theme “Futures of Listening” which is also a long-term project led by ACC Sound Art Lab. As part of the collaboration, the two programs will be jointly organizing creative support programs for participants including talks and workshops by four world-renowned soundscape experts. Based on these, residency participants are to develop and present concepts for individual projects exploring the theme. This will be followed by the actual production and realization of t

Students who enroll in William Altman's psychology classes at the State University of New York's Broome Community College sometimes find themselves hooked up to an electroencephalograph—a device that measures electrical activity of the brain—while driving simulated cars either with or without texting. Others in the class participate by monitoring the device's output or the number of accidents or driving errors both for drivers who text and those who refrain. "You don't get the excitement of students driving at 75 miles an hour into a parked fire truck if they're not in the room," Altman said. At the end of every class, Altman asks students to reflect in writing about what they learned or what confused them that day. Those who are present and submit the reflection receive participation credit that, over the semester, typically constitutes “a couple percent” of their course grade—an amount Altman deems negligible but effective. That is, students general